Cost of lumizyme?

Who covers the cost of Lumizyme?

Lumizyme, also known as alglucosidase alfa, is a recombinant form of the enzyme glucocerebroidase, used to treat Pompe disease, a rare genetic disorder. [1] The medication is expensive, with a cost that varies depending on the treatment center, insurance coverage, and individual patient circumstances.

How much does Lumizyme cost?

As of 2023, the average wholesale price (AWP) of Lumizyme is around $375,000 per year, with prices ranging from $300,000 to $500,000 annually. However, prices may be significantly higher for patients without adequate insurance coverage. [2]

Cost-sharing responsibilities

Patients with commercial insurance may be responsible for copays, coinsurance, or deductibles, which can range from 10% to 50% of the medication's cost. Medicaid and other government programs may have different cost-sharing requirements. [3]

Patient assistance programs

Biogen, the manufacturer of Lumizyme, offers patient assistance programs to help eligible patients cover the costs of the medication. These programs may include free or reduced-cost medication, as well as financial assistance for treatment-related expenses.

References

[1] Biogen, Inc. (2022). Lumizyme (alglucosidase alfa) injection for intravenous use.

[2] The Centers for Medicare and Medicaid Services (CMS). (2023). Medicare Coverage Database.

[3] Patient Advocate Foundation. (2023). Lumizyme (alglucosidase alfa) – Cost Assistance Programs.

Note: For the most up-to-date pricing information, please consult a pharmaceutical pricing database, such as the CMS Medicare Prescription Drug Policy or the FDA Orange Book.